References
The IFNB Multiple Sclerosis Study Group:Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Neurology 43: 655–661, 1993.
Johnson K.P., Brooks B.R., Cohen J.A., Ford C.C., Goldstein J., Lisak R.P., Myers L.W., Penitch H.S., Rose J.W., Schiffer R.B. et al.:Copolymer-1 reduces relapse rate and improved disability relapsing-remitting multiple sclerosis. Results for a phase III multicentre, double-blind, placebo-controlled trial. Neurology 45: 1268–1276, 1995.
Jacobs L.D., Cookfair D.L., Rudick R.A., Herndon R.M., Richert J.R., Salazar A.M., Fischer J.S., Goodkin D.E., Granger C.V., Simon J.H. et al.:Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann. Neurol. 39: 285–294, 1996.
Filippi M., Horsfield M.A., Tofs P.S., Barkhof F., Thompson A.J., Miller D.H.:Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 118: 1601–1612, 1995.
Miller D.H., Albert P.S., Barkhof F., Francis G., Frank J.S., Hodgkinson S., Lublin F.D., Paty D.W., Reingold S.C., Simon J.:Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann. Neurol., 39: 6–16, 1996.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miller, D.H. The use of MRI in monitoring the treatment of multiple sclerosis. Ital J Neuro Sci 17, 383–384 (1996). https://doi.org/10.1007/BF01997711
Issue Date:
DOI: https://doi.org/10.1007/BF01997711